GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
51.23
-0.31 (-0.60%)
Nov 10, 2026, 4:00 PM EST - Market closed
GSK Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, GSK stock has a consensus rating of "Hold" and an average price target of $59.12. The average 1-year stock price forecast is 15.40% higher than the current stock price, while the lowest is $49 (-4.35%) and the highest is $70 (+36.64%).
Price Target: $59.12 (+15.40%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for GSK stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 7 | 8 | 8 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Downgrades $67 → $56 | Hold | Downgrades | $67 → $56 | +9.12% | Oct 29, 2026 |
Unknown Analyst Berenberg Bank No rating | Berenberg Bank | Buy Upgrades $60 | Buy | Upgrades | $60 | +17.12% | Sep 16, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $70 | Hold | Maintains | $70 | +36.64% | Aug 3, 2026 |
| Argus Research | Argus Research | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 8, 2026 |
Financial Forecast
Revenue This Year
33.84B
from 32.67B
Increased by 3.59%
Revenue Next Year
35.27B
from 33.84B
Increased by 4.24%
EPS This Year
1.79
from 1.72
Increased by 4.36%
EPS Next Year
1.88
from 1.79
Increased by 4.66%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.